Skip to main content
hosted by
Search
Main navigation
Who We Are
Stop TB Partnership
Our Journey
Work with us
The Secretariat
The board
Board Members
Board Meetings
12-14 December 2024, Abuja, Nigeria
6-8 February 2024, Brasilia, Brazil.
23-26 March 2023, Varanasi, India
19-20 May 2022, Hybrid
28-30 September 2021, Virtual
18-20 November 2020, Virtual
11-12 December 2019, Jakarta, Indonesia
29-30 January 2019: Geneva, Switzerland
March 2018: New Delhi, India
17-18 May 2017: Berlin, Germany
19-20 September 2016: New York, USA
29 November 2015: Cape Town, South Africa
14-15 April 2015: Paris, France
15 July 2014, Seattle, USA
14 July 2014, Seattle, USA (Retreat)
January 2014, Cape Town, South Africa
July 2013, Ottawa, Canada
July 2013, Ottawa, Canada (Retreat)
November 2012: Kuala Lumpur, Malaysia
January 2012: Bangkok, Thailand
January 2012: Bangkok, Thailand (Retreat)
March / April 2011: Washington DC, USA
October 2010: Johannesburg, South Africa
May 2010: Hanoi, Viet Nam
November 2009: Geneva, Switzerland
March 2009: Rio de Janeiro, Brazil
October 2008: Bagamoyo, Tanzania
May 2008: Cairo, Egypt
October 2007: Berlin, Germany
April 2007: Geneva, Switzerland
November 2006: Jakarta, Indonesia
April 2006: Abuja, Nigeria
November 2005: Assisi, Italy
May 2005: Addis Ababa, Ethiopia
October 2004: Beijing, China
March 2004: New Delhi, India
October 2003: The Hague, Netherlands
April 2003: Brasilia, Brazil
October 2002: Cape Town, South Africa
February 2002: Osaka, Japan
Other meetings
Board Committees
Executive Committee
Executive Committee Minutes
Finance Committee
Board Delegations
Affected Communities Delegation
Developing Country NGO Constituency Delegation
Developed Country NGO Constituency Delegation
Work of the Developed Country NGO Delegation
Private Sector Providers Constituency Delegation
Innovations Constituency Delegation
Report of Decision Points
Board Affairs Documents and News
Stop TB Working Groups
Child and Adolescent TB
2021 Virtual annual meeting
2020 Virtual annual meeting
2019 Annual meeting
First paediatric antituberculosis drug optimization (PADO TB 1) meeting, February 2019
2018 Annual Meeting
Committing to ending TB in children, adolescents and families, 24 September 2018
2017 Annual Meeting
2016 Annual Meeting
2014 Annual Meeting
2013 Annual Meeting
Annual meeting of the Childhood TB Subgroup, Kuala Lumpur, Malaysia, 11 November 2012
Past Events
2022 Virtual annual meeting
Meetings Child & Adolescent TB
2024 Annual Meeting
2023 Annual Meeting
Objectives
Core Team Child & Adolescent TB
Structure
Chair of the Child & Adolescent TB Working Group.
Secretariat - Child & Adolescent TB Working Group.
Vice Chair of the Child & Adolescent TB Working Group Working Group
Repository of Resources
Publications
Ethambutol efficacy and toxicity:
Roadmap towards ending TB in children and adolescents 2nd Edition
Roadmap towards ending TB in children and adolescents 3rd Edition
End TB Transmission Initiative
ETTi Working Group Team
ETTi Working Group Team Members
ETTi - Technical Readings
ETTi - TB and Airborne Workshops & Webinars
ETTi - TB and Airborne IPC Guidance
ETTi - Virtual library of good practices
ETTi - Meetings & Events
ETTi - Newsletters & Social Media
ETTi - Feedback
Global Drug-resistant TB Initiative
Resources
GDI Governance
GDI Mission
GDI Terms of Reference
What's new at GDI
GDI Structure
Chair of the GDI Working Group
Vice Chair of the GDI Working Group
GDI Meetings
Global Laboratory Initiative (GLI)
GLI Mission
GLI News
GLI Guidance and Tools
GLI Specimen Referral Toolkit
TB Laboratory Accreditation
GLI Quick Guide to TB Diagnostics Connectivity Solutions
GLI Stepwise Process towards TB Laboratory Accreditation
GLI TB Laboratory Safety Handbook
GLI guide for the interpretation and reporting of line probe assays
Planning and Budgeting Tool for TB and drug resistant TB testing
Practical Guide to Implementation of Truenat tests
Practical implementation of LF-LAM for detection of active TB in people living with HIV
Standard Operating Procedures (SOPs)
Training Packages
Diagnostic network strengthening and Xpert MTB/RIF (Ultra) implementation
Programme Modules for Diagnostic Network Strengthening
XPERT MTB/RIF
Partner Links
Join Us
GLI EQA Dashboard
GLI working group - Team members
Meetings & Events
GLI Webinars
Implementing tNGS for Detection of Drug-Resistant TB in High Burden Countries
New Diagnostics
Task Force on Biomarkers for TB point-of-care tests
Bm2Dx TB Biomarker database
Task Force on NGS and DST
TPP on next-generation DST at peripheral level - Update
Advocacy fact sheet
Data Sharing
1st NDWG workshop on sequencing data sharing
2nd NDWG Workshop - Data sharing to improve management of drug resistant TB
Task Force on TBI and test of progression
Model to evaluate the impact of a test for incipient TB
TPP and Framework for evaluation for a test of progression of LTBI
2nd Expert Workshop on the development of tests for progression of latent tuberculosis infection (LTBI) to active disease
Resources on TBI
News
Task Force on Community Engagement
New Diagnostics Working Group Resources
Guidelines & Policies
Publications
Scientific Articles
News Archive
Newsletters
Links
NDWG - About us
NDWG - Our Team
NDWG - Task Forces
NDWG - Publications
Meetings & Events
NDWG Annual Meeting 2021
NDWG Annual Meeting 2020
NDWG Annual Meeting 2019
NDWG Annual Meeting 2018
NDWG Annual Meeting 2017
NDWG Annual Meeting 2016
NDWG Annual Meeting 2015
NDWG Annual Meeting 2014
NDWG Annual Meeting 2013
NDWG Annual Meeting 2012
NDWG Annual Meeting 2011
NDWG Annual Meeting 2010
NDWG Annual Meeting 2009
NDWG Annual Meeting 2008
NDWG Annual Meeting 2007
NDWG Annual Meeting 2006
Events Archive
NDWG Annual Meeting 2004
Subgroup on Community, Poverty and Advocacy
Subgroup on Diagnostics for Latent TB Infection
Subgroup on Diagnostics for Paediatric TB
Subgroup on Drug Susceptibility Testing
Subgroup on Evidence Synthesis and Policy
Subgroup on Point Of Care Diagnosis
New TB Drugs
New TB Vaccines
Public-Private Mix (PPM) For TB Care and Prevention
Core Group
Objectives
PPM Learning network to End TB launched at the Union World Conference on Lung Health
PPM Working Group News
16th Global PPM Working Group Meeting - News Report
17th Global PPM Working Group Meeting - News Report
News Archive
14th Global PPM Working Group Meeting - Report News
New Publication
PPM Working Group Key Documents
PPM Working Group Meetings
17th Global PPM Working Group Meeting
16th Global PPM Working Group Meeting
15th Global PPM Working Group Meeting
18TH Global PPM Working Group Meeting
Mini-Meet PPM Group May 2021
WHO consultation on enhanced TB-PPM Dashboards with seven PPM priority countries
19TH Global PPM Working Group Meeting
14th Global PPM Working Group Meeting
Structure
Chair of the PPM Working Group
The Secretariat - PPM Working Group
13th PPM Working Group Meeting
What we do
Advocate To #EndTB
Advocacy and Communications
BCG
Stop TB in the News
One World TB Summit
Global Impact of Tuberculosis - Press Conference
Bedaquiline Agreement
UN HLM on TB media coverage
Global Drug Facility (GDF) announced price reductions up to 55% for bedaquiline
Press tour to Mozambique
Stop TB Head and TB Champion raise awareness of link between TB and AMR
World TB Day
World TB Day 2025
World TB Day 2024
Your Events
Social Media Challenge
Wall of Fame
Light up For TB
World TB Day 2023
Your Events
Social Media Challenge
Wall of Fame
World TB Day 2022
DO IT YOURSELF
Digital Billboards
Wall of Fame
Your events
World TB Day 2021
2021 Highlights
About the 2021 campaign
Do It Yourself
Join the Campaign
Your Photos
World TB Day 2020
Quick Actions
More Actions
Campaign Materials
Events Near You
Your Photos
TB and COVID-19
UN High-Level Meeting on TB
UN High-Level Meeting on TB 2023
Global Fund Disease Split
Global Plan to End TB
Global Plan to End TB 2023-2030
Step up for TB: National TB Policies
Tuberculosis Research Funding Trends, 2005-2023
Hello Kitty
The G20
Supporting communities to overcome access barriers
Funding people affected by TB and local communities
Community-Led Monitoring
Addressing Barriers to TB Sevices
Declaration of Rights of People Affected by TB
TB Stigma and Access Discussion Group
End TB Stigma
Addressing Demographic Disparities in TB
Empower people affected by TB
Strengthen Country-level Partnerships
Partnering Process
Partnership Building
Partnership Exploration
Partnership Maintenance
Award those who care
ACCELERATE TB INNOVATIONS, DIGITAL TECHNOLOGY AND ARTIFICIAL INTELLIGENCE (AI)
TB REACH
How TB REACH Works
The Team
TB REACH Impact
Catalyzing Diagnostic Use
TB REACH Xpert Budget Estimation Tool
Ground Up Innovation
Monitoring Success
Waves of Funding
Wave 11
Wave 10
Wave 9
Wave 8
TB REACH Wave 8 Application
TB REACH Wave 8 Proposal Review Committee Application
Wave 8 Application Resources
Wave 7
Wave 6
Wave 6 Digital Adherence Technology Projects
Wave 5
Approved Projects
Project Summaries
Results
Wave 4
Approved Projects
Project Summaries
Results
Wave 3
Approved Projects
Project Summaries
Results
Wave 2
Approved Projects
Project Summaries
Results
Wave 1
Approved Projects
Project Summaries
Results
TB Reach publications
Re-imagining TB care
Digital Health Technology Hub
AI-Powered Cough Analysis and Monitoring
AI-Powered Computer-Aided Detection (CAD) Software
Case Studies
Evaluations
Focus Group on AI-based Imaging for TB
CAD and X-ray experience sharing from India
FG-AITB Webinar 5 - Pakistan Experience
FG-AITB Webinar 6 - Cambodia Experience
FG-AITB Webinar 7 - Vietnam Experience
FG-AITB Webinar 8 - Uganda Experience
FG-AITB Webinar 9 - Janna Health Foundation Experiences in Nigeria
Implementing CAD and Ultra-Portable X-ray in Nigeria
Resources for Implementing CAD and X-ray
CAD and X-ray Practical Implementation Guide
CAD and X-ray Training Modules
Community-Led Monitoring Tools
Diagnostics Connectivity Solutions
Digital Adherence Technologies
Global DAT Task Force
The Introducing New Tools Project
Artificial intelligence-powered computer-aided detection (CAD) software
Country experiences
Rapid molecular diagnostics for use at peripheral level
Truenat training modules
Next-generation skin tests
Ultra-portable digital X-ray systems
Interferon Gamma Release Assays for detection of TB infection
Digital treatment adherence and support technologies
Diagnostics connectivity solutions
Targeted next-generation sequencing
Resources for implementation
Access pricing
Facilitate Access to TB Drugs & Diagnostics
Global Drug Facility (GDF)
Mission
Market & Partner Coordination
TB Medicines Dashboard
Stakeholder coordination and TPMAT
Buyers
Plan an Order
Place an Order
Medicines
Diagnostics
Track an Order
Suppliers
How to become a StopTB/GDF supplier
Medicines
Suppliers of TB Diagnostics, Medical Devices & Laboratory supplies
Quality Assurance
Procurement Notices
Archived procurement notices
GDF Supplier Meetings
Supplier Information
New Tools
Diagnostics
Access pediatric formulations
Bedaquiline
Bedaquiline Donation Program 2015-2019
Delamanid
Access Pretomanid
Access TPT
Products Catalog
Technical Assistance
Provide technical support and capacity building
Partner With Us
Why Become a Partner
How to become a Partner
The benefits of partnership
Our Partners
Joining Forces To #EndTB
Additional resources
Resources
World TB Day
Interactive TB data
Interactive Country Dashboard
Interactive Map Dashboard
Treatment Dashboard
Digital TB Assessment
GDF Resources
TB & COVID
Publications
Governance of TB programs
Overcoming Barriers to TB Services
At A Glance
What is Tuberculosis?
News
News
Events
Newsletter
Donate
Breadcrumb
Home
We Now Have a Chance To Stop The Most Deadly Infectious Disease — If We Act
We Now Have a Chance to Stop the Most Deadly Infectious Disease — if We Act
NYTimes op-ed on TB
